Wordt geladen...
Choosing chemotherapy in patients with advanced urothelial cell cancer who are unfit to receive cisplatin-based chemotherapy
Transitional cell carcinoma of the urothelial tract is the second most common cancer of the genitourinary system and the fifth most common cancer in Western countries with more than 300,000 new cases per year worldwide. Following the introduction of cisplatin-based chemotherapy, median overall survi...
Bewaard in:
Hoofdauteurs: | , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
SAGE Publications
2010
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126029/ https://ncbi.nlm.nih.gov/pubmed/21789149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834010376185 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|